Yamamoto Hiromasa 山本寛斉

… Alternative Names

Researcher Number	40467733
Other IDs	https://orcid.org/0000-0002-5330-5460
Affiliation (Current)	2022: 岡山大学, 大学病院, 講師
Affiliation (based on the past Project Information) *help	2022: 岡山大学, 大学病院, 講師 2012 – 2021: 岡山大学, 大学病院, 助教 2017: 岡山大学, 岡山大学病院, 助教 2015: 岡山大学, 病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 55040:Respiratory surgery-related / Thoracic surgery / Respiratory surgery Except Principal Investigator Respiratory surgery / Basic Section 55040:Respiratory surgery-related / Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields / Basic Section 55010:General surgery and pediatric surgery-related / Basic Section 50010:Tumor biology-related
Keywords	Principal Investigator 肺癌 / 原発性肺癌 / Hsp90阻害剤 / 放射線治療 / EGFRチロシンキナーゼ阻害剤耐性 / 薬剤耐性機構 / マイクロRNA / 上皮間葉移行 / 上皮間葉系移行 / EGFR … More Except Principal Investigator 肺癌 / HER2 / 薬剤耐性 / 悪性胸膜中皮腫 / 癌 / 外科 / 癌幹細胞 / 非小細胞肺癌 / 次世代シーケンサー / 原発性肺癌 / 上皮成長因子受容体チロシンキナーゼ阻害剤 / 上皮間葉移行 / 上皮成長因子受容体チロシンキナーゼ阻害薬 / マイクロRNA / 遺伝子変異 / チロシンキナーゼ阻害剤 / REIC遺伝子 / 遺伝子治療 / REIC / NK細胞 / MHC Class I / GRP78 / MHC Class-I / MHC Class1 / 分子標的薬 / 分子バーコード / 次世代シークエンサー / EMT / PDX / 分子標的治療薬 / EGFR / サイトケラチン19 / ERBB2 / メトホルミン / 抗PD-1抗体 / EGFR-TKI耐性 / ABCB1阻害剤 / Elacrida / 上皮成長因子受容体チロシンキナーゼ阻害剤耐性 / 癌微小環境 / 炎症 / 抗体療法 / 胸部悪性腫瘍 / 乳癌 / 耐性機序 / 耐性克服 / HER異常 / 肺がん / 乳がん / 胃がん / DCLK1 / 腫瘍幹細胞マーカー / ダメージ関連分子パターン / RAGE / 肺線維化 / ドライバー遺伝子変異 / EGFR遺伝子変異 / 肺腺がん / ドラッグリポジショニング / パスウェイ / 精密医療 / ドライバー遺伝子 / 家族性肺癌 / 次世代シーケンス / 胚細胞変異 / 腺癌 / 肺移植 / 虚血再灌流障害 / S100 / 非小細胞肺がん / がん微小環境 / がん関連線維芽細胞 Less

マトリセルラータンパク質阻害によるがん微小環境の破壊と抗腫瘍効果の検討
- Principal Investigator
  
  豊岡伸一
- Project Period (FY)
  2022 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Okayama University
Exploration of the novel therapeutic target for lung cancer based on the analysis of the characteristics of tumor cells derived from 3D culturePrincipal Investigator
- Principal Investigator
  
  山本寛斉
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Okayama University
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
- Principal Investigator
  
  冨田秀太
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Okayama University
家族性肺癌に対する、次世代シーケンサーを用いた胚細胞性遺伝子変異と治療法の探索
- Principal Investigator
  
  牧佑歩
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  National Hospital Organization Shikoku Cancer Center
肺虚血再灌流障害におけるS100A8/A9の役割の解明と新しい治療法の開発
- Principal Investigator
  
  岡崎幹生
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Okayama University
HER2標的薬に対する乳癌細胞の獲得耐性克服を目指した治療戦略の開発
- Principal Investigator
  
  枝園忠彦
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Okayama University
HER2異常肺癌に対する新しい治療法の開発
- Principal Investigator
  
  宗淳一
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Kindai University
Novel treatment strategy for malignant pleural mesothelioma targeting the tumor stem cell marker DCLK1
- Principal Investigator
  
  三好新一郎
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Okayama University
Development of the novel therapy focused on damage-associated molecular patterns (DAMPs) for lung fibrosis-related diseases
- Principal Investigator
  
  豊岡伸一
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Okayama University
Novel therapeutic strategy focused on EGFR-binding protein LRIG1 for EGFR-mutant lung cancerPrincipal Investigator
- Principal Investigator
  
  Yamamoto Hiromasa
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Okayama University
Development of innovative therapeutic antibodies targeting the inflammatory tumor microenvironment in refractory thoracic tumors
- Principal Investigator
  
  Toyooka Shinichi
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields
- Research Institution
  Okayama University
Development of new therapeutic strategy based on gene expression and mutation profiles in EGFR mutant lung cancer
- Principal Investigator
  
  Toyooka Shinichi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
Novel therapeutic method for HER2 active cancer focusing on HER2 novel binding molecule cytokeratin 19
- Principal Investigator
  
  SOH JUNICHI
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
Development of new immunotherapy for lung cancer by combined application of diabetes drug metformin and anti-PD-1 antibody
- Principal Investigator
  
  Miyoshi Shinichiro
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
Clarification of the mechanism of drug resistance focused on microRNAs associated with epithelial-mesenchymal transition in lung cancerPrincipal Investigator
- Principal Investigator
  
  Yamamoto Hiromasa
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
Development of new therapeutic strategy for EGFR-TKI resistant non-small cell lung cancer.
- Principal Investigator
  
  Asano Hiroaki
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
Identification of novel targets in the treatment of lung cancer
- Principal Investigator
  
  Miyoshi Shinichiro
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
New therapeutic strategy for non-small cell lung cancer by REIC gene therapy
- Principal Investigator
  
  Toyooka Shinichi
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
Understanding and overcoming drug resistance to EGFR-inhibitors for lung cancer
- Principal Investigator
  
  Toyooka Shinichi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
New treatment strategy for malignant pleural mesothelioma focusing on microRNAs related to cancer stem cell makers
- Principal Investigator
  
  SOH JUNICHI
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory surgery
- Research Institution
  Okayama University
The new strategy for lung cancer treatment by Hsp90 inhibitors and radiation therapyPrincipal Investigator
- Principal Investigator
  
  YAMAMOTO Hiromasa
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Thoracic surgery
- Research Institution
  Okayama University

All 2021 2020 2019 2018 2017 2016 2015 2014 Other

All Journal Article Presentation

[Journal Article] The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.2021
- Author(s)
  Araki K, Kinoshita R, Tomonobu N, Yamamoto KI, Murata H, Suzawa K, Shien K, Yamamoto H, Okazaki M, Nishibori M, Miyahara N, Toyooka S, Sakaguchi M.
- Journal Title
  
  J Mol Med (Berl)
  
  Volume: 99 Pages: 131-145
- DOI
  10.1007/s00109-020-02001-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07369, KAKENHI-PROJECT-19H03746, KAKENHI-PROJECT-20H03516, KAKENHI-PROJECT-16H06277
[Journal Article] YES1 activation induces acquired resistance to neratinib in HER2-amplified breast and lung cancers2020
- Author(s)
  Takeda Tatsuaki、Yamamoto Hiromasa、Suzawa Ken、Tomida Shuta、Miyauchi Shunsaku、Araki Kota、Nakata Kentaro、Miura Akihiro、Namba Kei、Shien Kazuhiko、Soh Junichi、Shien Tadahiko、Kitamura Yoshihisa、Sendo Toshiaki、Toyooka Shinichi
- Journal Title
  
  Cancer Sci
  
  Volume: 111 Pages: 849-856
- DOI
  10.1111/cas.14289
- NAID
  120006839439
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09070, KAKENHI-PROJECT-19K09285, KAKENHI-PROJECT-17K10784
[Journal Article] Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic BRAF Mutation.2020
- Author(s)
  Miyauchi S, Shien K, Takeda T, Araki K, Nakata K, Miura A, Tomida S, Yamane M, Sakaguchi M, Toyooka S.
- Journal Title
  
  Anticancer Res
  
  Volume: 40 Pages: 2667-2673
- DOI
  10.21873/anticanres.14237
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H03516, KAKENHI-PROJECT-20H03771, KAKENHI-PROJECT-16H06277
[Journal Article] Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer2020
- Author(s)
  Ochi Kosuke、Suzawa Ken、Tomida Shuta、Shien Kazuhiko、Takano Jui、Miyauchi Shunsaku、Takeda Tatsuaki、Miura Akihiro、Araki Kota、Nakata Kentaro、Yamamoto Hiromasa、Okazaki Mikio、Sugimoto Seiichiro、Shien Tadahiko、Yamane Masaomi、Azuma Kazuo、Okamoto Yoshiharu、Toyooka Shinichi
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 529 Pages: 760-765
- DOI
  10.1016/j.bbrc.2020.06.077
- NAID
  120007120054
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20H03771
[Journal Article] Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations.2019
- Author(s)
  Ogoshi Y, Shien K, Yoshioka T, Torigoe H, Sato H, Sakaguchi M, Tomida S, Namba K, Kurihara E, Takahashi Y, Suzawa K, Yamamoto H, Soh J, Toyooka S
- Journal Title
  
  Oncol Lett
  
  Volume: - Pages: 2729-2736
- DOI
  10.3892/ol.2019.9908
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H03577, KAKENHI-PROJECT-16K10681
[Journal Article] Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non?Small Cell Lung Cancer Cells2019
- Author(s)
  Namba Kei、Shien Kazuhiko、Takahashi Yuta、Torigoe Hidejiro、Sato Hiroki、Yoshioka Takahiro、Takeda Tatsuaki、Kurihara Eisuke、Ogoshi Yusuke、Yamamoto Hiromasa、Soh Junichi、Tomida Shuta、Toyooka Shinichi
- Journal Title
  
  Molecular Cancer Research
  
  Volume: 17 Pages: 499-507
- DOI
  10.1158/1541-7786.mcr-18-0628
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K10784, KAKENHI-PROJECT-16H05431, KAKENHI-PROJECT-17K16608
[Journal Article] Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naive lung adenocarcinoma2019
- Author(s)
  Namba Kei、Tomida Shuta、Matsubara Takehiro、Takahashi Yuta、Kurihara Eisuke、Ogoshi Yusuke、Yoshioka Takahiro、Takeda Tatsuaki、Torigoe Hidejiro、Sato Hiroki、Shien Kazuhiko、Yamamoto Hiromasa、Soh Junichi、Tsukuda Kazunori、Toyooka Shinichi
- Journal Title
  
  BMC Cancer
  
  Volume: 19 Pages: 1-9
- DOI
  10.1186/s12885-019-5374-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10784, KAKENHI-PROJECT-16H05431
[Journal Article] Acquired resistance mechanisms to afatinib in HER 2 ‐amplified gastric cancer cells2019
- Author(s)
  Yoshioka, T. Shien, K. Takeda, T. Takahashi, Y. Kurihara, E. Ogoshi, Y. Namba, K. Torigoe, H. Sato, H. Tomida, S. Yamamoto, H. Soh, J. Fujiwara, T. Toyooka, S.
- Journal Title
  
  Cancer Science
  
  Volume: 110 Pages: 2549-2557
- DOI
  10.1111/cas.14089
- NAID
  120006816640
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09285, KAKENHI-PROJECT-17K10784
[Journal Article] Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.2018
- Author(s)
  Torigoe H, Yamamoto H, Sakaguchi M, Youyi C, Numba K, Sato H, Shien K, Soh J, Suzawa K, Tomida S, Tsukuda K, Miyoshi S, Toyooka S
- Journal Title
  
  Carcinogenesis
  
  Volume: - Pages: 719-727
- DOI
  10.1093/carcin/bgy044
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H03577, KAKENHI-PROJECT-18K08783
[Journal Article] Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer2018
- Author(s)
  Yoshioka T, Shien K, Namba K, Torigoe H, Sato H, Tomida S, Yamamoto H, Asano H, Soh J, Tsukuda K, Nagasaka T, Fujiwara T, Toyooka S.
- Journal Title
  
  Cancer Sci
  
  Volume: 109 Pages: 1166-1176
- DOI
  10.1111/cas.13546
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10681, KAKENHI-PROJECT-18K18464, KAKENHI-PROJECT-18H03554, KAKENHI-PROJECT-15H03034
[Journal Article] Therapeutic Potential of Afatinib for Cancers withERBB2(HER2) Transmembrane Domain Mutations G660D and V659E2018
- Author(s)
  Yamamoto H, Toyooka S, Ninomiya T, Matsumoto S, Kanai M, Tomida S, Kiura K, Muto M, Suzawa K, Desmeules P, Kris MG, Li BT, Ladanyi M.
- Journal Title
  
  The Oncologist
  
  Volume: 23 Pages: 150-154
- DOI
  10.1634/theoncologist.2017-0345
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10681, KAKENHI-PROJECT-17K10784, KAKENHI-PROJECT-18H02692
[Journal Article] Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.2017
- Author(s)
  Chen H, Shien K, Suzawa K, Tsukuda K, Tomida S, Sato H, Torigoe H, Watanabe M, Namba K, Yamamoto H, Soh J, Asano H, Miyoshi S, Toyooka S
- Journal Title
  
  Oncology Letters
  
  Volume: 14(4) Pages: 4349-4354
- DOI
  10.3892/ol.2017.6678
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K10258
[Journal Article] Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies.2017
- Author(s)
  Suzawa K, Shien K, Peng H, Sakaguchi M, Watanabe M, Hashida S, Maki Y, Yamamoto H, Tomida S, Soh J, Asano H, Tsukuda K, Nasu Y, Kumon H, Miyoshi S, Toyooka S.
- Journal Title
  
  Anticancer Research
  
  Volume: 37 Pages: 301-307
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26670627
[Journal Article] Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features2017
- Author(s)
  Sato H, Shien K, Tomida S, Okayasu K, Suzawa K, Hashida S, Torigoe H, Watanabe M, Yamamoto H, Soh J, Asano H, Tsukuda K, Miyoshi S, Toyooka S.
- Journal Title
  
  Scientific Reports
  
  Volume: 7 Pages: 40847-40847
- DOI
  10.1038/srep40847
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PUBLICLY-16H01574, KAKENHI-PROJECT-16H06988, KAKENHI-PROJECT-15K19935
[Journal Article] Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway2016
- Author(s)
  Ohtsuka T, Sakaguchi M, Yamamoto H, Tomida S, Takata K, Shien K, Hashida S, Miyata-Takata T, Watanabe M, Suzawa K, Soh J, Youyi C, Sato H, Namba K, Torigoe H, Tsukuda K, Yoshino T, Miyoshi S, Toyooka S.
- Journal Title
  
  Sci Rep
  
  Volume: 6 Pages: 39557-39557
- DOI
  10.1038/srep39557
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PUBLICLY-16H01574, KAKENHI-PROJECT-26293318, KAKENHI-PROJECT-26293352, KAKENHI-PROJECT-15K14382, KAKENHI-PROJECT-16K10681
[Journal Article] Antitumor effect of afatinib, as a HER2-targeted therapy, in lung cancers harboring HER2 oncogene alterations.2016
- Author(s)
  Ken Suzawa, Shinichi Toyooka, Masakiyo Sakaguchi, Mizuki Morita, Hiromasa Yamamoto, Shuta Tomida, Tomoaki Ohtsuka, Mototsugu Watanabe, Shinsuke Hashida, Yuho Maki, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda and Shinichiro Miyoshi
- Journal Title
  
  Cancer Sci
  
  Volume: 107 Pages: 45-52
- DOI
  10.1111/cas.12845
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26293318, KAKENHI-PROJECT-26293352
[Journal Article] Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma.2016
- Author(s)
  Suzawa K, Yamamoto H, Murakami T, Katayama H, Furukawa M, Shien K, Hashida S, Okabe K, Aoe K, Soh J, Asano H, Tsukuda K, Mimura Y, Toyooka S, Miyoshi S
- Journal Title
  
  Oncol Lett
  
  Volume: 1 Pages: 705-712
- DOI
  10.3892/ol.2015.3955
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462195
[Journal Article] Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib2015
- Author(s)
  Shinsuke Hashida, Hiromasa Yamamoto, Kazuhiko Shien, Yuichiro Miyoshi, Tomoaki Ohtsuka, Ken Suzawa, Mototsugu Watanabe, Yuho Maki, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyooka
- Journal Title
  
  Cancer Science
  
  Volume: 10 Pages: 1377-1384
- DOI
  10.1111/cas.12749
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25293302
[Journal Article] Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors2015
- Author(s)
  Hashida S, Yamamoto H, Shien K, Ohtsuka T, Suzawa K, Maki Y, Furukawa M, Soh J, Asano H, Tsukuda K, Miyoshi S, Kanazawa S, Toyooka S
- Journal Title
  
  Oncology Reports
  
  Volume: 33 Pages: 1499-1504
- DOI
  10.3892/or.2015.3735
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24791462, KAKENHI-PROJECT-25293302
[Journal Article] TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells.2015
- Author(s)
  Otani H, Yamamoto H, Takaoka M, Sakaguchi M, Soh J, Jida M, Ueno T, Kubo T, Asano H, Tsukuda K, Kiura K, Hatakeyama S, Kawahara E, Naomoto Y, Miyoshi S, Toyooka S
- Journal Title
  
  PLoS One.
  
  Volume: 10
- DOI
  10.1371/journal.pone.0129838
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K14382, KAKENHI-PROJECT-15H04830, KAKENHI-PROJECT-25293302, KAKENHI-PROJECT-26290039
[Journal Article] Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer2014
- Author(s)
  Shien K, Tanaka N, Watanabe M, Soh J, Sakaguchi M, Matsuo K, Yamamoto H, Furukawa M, Asano H, Tsukuda K, Nasu Y, Huh NH, Miyoshi S, Kumon H, Toyooka S
- Journal Title
  
  PloS one
  
  Volume: 9
- DOI
  10.1371/journal.pone.0087900
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26290039, KAKENHI-PROJECT-26670627
[Presentation] Doublecortin-like Kinase 1 (DCLK1) correlates with the cell proliferation in malignant pleural mesothelioma2019
- Author(s)
  Akihiro Miura, Hiromasa Yamamoto, Hiroyuki Tao, Ken Suzawa, Shunsaku Miyauchi, Kota Araki, Yuta Takahashi, Eisuke Kurihara, Yusuke Ogoshi, Kazuhiko Shien, Junichi Soh, Kazunori Okabe, Shuta Tomida, Masakiyo Sakaguchi, Shinichi Toyooka
- Organizer
  AACR Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09286
[Presentation] Activation of AXL as a preclinical acquired resistance mechanism against osimertinib treatment in EGFR-mutant non-small cell lung cancer cells2019
- Author(s)
  Kei Namba, Kazuhiko Shien, Yuta Takahashi, Hiroki Sato, Takahiro Yoshioka, Ken Suzawa, Hiromasa Yamamoto, Junichi Soh, Shuta Tomida, Shinichi Toyooka
- Organizer
  AACR Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05431
[Presentation] Clinicopathological characteristics of lung cancer patients with concomitant idiopathic pulmonary fibrosis2019
- Author(s)
  Kota Araki, Kazuhiko Shien, Shunsaku Miyauchi, Akihiro Miura, Yuta Takahashi, Eisuke Kurihara, Yusuke Ogoshi, Kei Namba, Ken Suzawa, Hiromasa Yamamoto, Shuta Tomida, Junichi Soh, Masakiyo Sakaguchi, Shinichi Toyooka
- Organizer
  AACR Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19581
[Presentation] EGFR 変異陽性肺癌における LRIG1 の抗腫瘍効果2018
- Author(s)
  鳥越英次郎、山本寛斉、阪口政清、難波圭、佐藤博紀、枝園和彦、諏澤憲、宗淳一、冨田秀太、佃和憲、三好新一郎、豊岡伸一
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K08783
[Presentation] Antitumor effect of neratinib in lung cancers harboring HER2 oncogene alterations2018
- Author(s)
  Yusuke Ogoshi, shinichi Toyooka, Jyunichi Soh, hiromasa Yamamoto, Kazuhiko Shien, Hidejiro torigoe, Hiroki sato, Takahiro Yoshioka, Kei Namba, Yuta Takahashi, and Eisuke Kurihara
- Organizer
  AACR2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10681
[Presentation] Metformin improves immune function of exhausted peripheral CD8+ T cells derived from cancer patients2017
- Author(s)
  Mototsugu Watanabe, Shingo Eikawa, Kazuhiko Shien, Hiromasa Yamamoto, Tadahiko Shien, Junichi Soh, Hiroyoshi Doihara, Shinichi Toyooka, Shinichiro Miyoshi, Heiichiro Udono
- Organizer
  AACR Annual Meeting 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K15637
[Presentation] Multiple acquired resistance mechanisms against third generation EGFR-TKI osimertinib in non-small cell lung cancer cells2017
- Author(s)
  Kei Namba, Kazuhiko Shien, Hidejiro Torigoe, Hiroki Sato, Hiromasa Yamamoto, Junichi Soh, Kazunori Tsukuda, Shinichi Toyooka
- Organizer
  第58回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-16H05431
[Presentation] Detection of multiple low-frequency mutations by molecular-barcode sequencing2017
- Author(s)
  Kei Namba, Shuta Tomida, Hidejiro Torigoe, Hiroki Sato, Kazuhiko Shien, Hiromasa Yamamoto, Junichi Soh, Kazunori Tsukuda, Shinichi Toyooka
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16H05431
[Presentation] 悪性胸膜中皮腫に対するREIC/Dkk-3遺伝子治療2016
- Author(s)
  山本寛斉、諏澤憲、枝園和彦、宗淳一、三好健太郎、大谷真二、杉本誠一郎、山根正修、大藤剛宏、三好新一郎、豊岡伸一
- Organizer
  第69回日本胸部外科学会定期学術集会
- Place of Presentation
  岡山
- Year and Date
  2016-09-28
- Data Source
  KAKENHI-PROJECT-26670627
[Presentation] Detection of multiple low-frequency mutations by molecular-barcode sequencing2016
- Author(s)
  Kei Namba, Shuta Tomida, Ken Suzawa, Hidejiro Torigoe, Hiroki Sato, Hiromasa Yamamoto, Junichi Soh, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  IASLC 17TH WORLD CONFERENCE ON LUNG CANCER
- Place of Presentation
  Vienna, Austria
- Year and Date
  2016-12-04
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05431
[Presentation] Targeting miR-200c/Lin28B axis in acquired EGFR-TKI resistance non-small cell cancer cells harboring EMT features2016
- Author(s)
  Kazuhiko Shien, Hiroki Sato, Ken Suzawa, Shuta Tomida, Shinsuke Hashida, Hiromasa Yamamoto, Junichi Soh, Hidejiro Torigoe, Kei Namba, Mototsugu Watanabe, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyota
- Organizer
  World Conference on Lung Cancer 2016
- Place of Presentation
  Vienna, Austria
- Year and Date
  2016-12-04
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19935
[Presentation] Detection of multiple low-frequency mutations by molecular-barcode sequencing2016
- Author(s)
  Kei Namba, Shuta Tomida, Kazuhiko Shien, Hidejiro Torigoe, Hiroki Sato, Hiromasa Yamamoto, Junichi Soh, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  第57回日本肺癌学会総会
- Place of Presentation
  福岡市
- Year and Date
  2016-12-19
- Data Source
  KAKENHI-PROJECT-16H05431
[Presentation] Ｔhe proof of concept of REIC/Dkk-3 gene therapy for thoracic malignancies.2016
- Author(s)
  Shinichi Toyooka, Ken Suzawa, Kazuhiko Shien, Masakiyo Sakaguchi, Masami Watanabe, Peng Huang, Kei Namba, Hidejiro Torigoe, Hiroki Sato, Junichi Soh, Hiromasa Yamamoto, Yuho Maki, Kazunori Tsukuda, Shuta Tomida, Yasutomo Nasu, Hiromi Kumon, Shinichiro Miyoshi
- Organizer
  １０ｔｈ AACR-JCA Joint Conference on Breakthroughs in Cancer Research: From Biology to Therapeutics
- Place of Presentation
  米国
- Year and Date
  2016-02-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26670627
[Presentation] Cytokeratin 19 binds to HER2 and activates HER2 and its downstream signaling2016
- Author(s)
  Tomoaki Ohtsuka, Masakiyo Sakaguchi, Shuta Tomida, Hiromasa Yamamoto, Katsuyoshi Takata, Shinsuke Hashida, Mototsugu Watanabe, Ken Suzawa, Yuho Maki, Junichi Soh, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  Tenth AACR-JCA Joint Conference on Breakthroughs in Cancer Research: From Biology to Therapeutics
- Place of Presentation
  Maui, Hawaii, USA
- Year and Date
  2016-02-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293318
[Presentation] 胸部悪性腫瘍に対するREIC遺伝子治療2016
- Author(s)
  豊岡伸一、諏澤憲、枝園和彦、牧佑歩、山本寛斉、宗淳一、山根正修、大藤剛宏、公文裕巳、三好新一郎
- Organizer
  第116回日本外科学会定期学術集会
- Place of Presentation
  大阪
- Year and Date
  2016-04-14
- Data Source
  KAKENHI-PROJECT-26670627
[Presentation] Distant bystander effect of REIC/Dkk-3 gene therapy through immune system stimulation in a murine model of thoracic malignancies2015
- Author(s)
  Ken Suzawa, Kazuhiko Shien, Pen Huang, Masakiyo Sakaguchi, Mototsugu Watanabe, Shinsuke Hashida, Junichi Soh, Hiromasa Yamamoto, Yuho Maki, Hiroaki Asano, Kazunori Tsukuda, Yasutomo Nasu, Hiromi Kumon, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  16th World Conference on Lung Cancer
- Place of Presentation
  名古屋
- Year and Date
  2015-09-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26670627
[Presentation] Adenovirus-mediated REIC/Dkk-3 gene therapy shows indirect antitumor effects on thoracic malignancies through immune system stimulation2015
- Author(s)
  Ken Suzawa, Kazuhiko Shien, Masakiyo Sakaguchi, Masami Watanabe, Shinsuke Hashida, Junichi Soh, Hiromasa Yamamoto, Yuho Maki, Kazunori Tsukuda, Yasutomo Nasu, Hiromi Kumon, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  米国
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26670627
[Presentation] 悪性胸膜中皮腫に対するREIC/Dkk-3遺伝子治療2015
- Author(s)
  山本寛斉、枝園和彦、牧佑歩、宗淳一、大谷真二、三好健太郎、杉本誠一郎、山根正修、大藤剛宏、渡部昌実、那須保友、公文裕巳、三好新一郎、豊岡伸一
- Organizer
  第56回日本肺癌学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2015-11-26
- Data Source
  KAKENHI-PROJECT-26670627
[Presentation] Docetaxel-resitant non-small cell lung cancer cells that acquired cross-resistance to EGFR-tyrosine kinase inhibitor2015
- Author(s)
  Haiyang Chen, Ken Suzawa, Shinsuke Hashida, Tomoaki Ohtsuka, Mototsugu Watanabe, Yuho Maki, Hiromasa Yamamoto, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  第74回日本癌学会総会
- Place of Presentation
  名古屋
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25293302
[Presentation] Identification of a novel binding protein playing a critical role in HER2 activation in lung cancer cells2015
- Author(s)
  Tomoaki Ohtsuka, Masakiyo Sakaguchi, Katsuyoshi Takata, Shinsuke Hashida, Mototsugu Watanabe, Ken Suzawa, Yuho Maki, Hiromasa Yamamoto, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  AACR Annual Meeting 2015
- Place of Presentation
  Philadelphia, USA
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293318
[Presentation] 悪性胸膜中皮腫に対するREIC/Dkk-3遺伝子治療2015
- Author(s)
  山本寛斉、枝園和彦、牧佑歩、宗淳一、大谷真二、三好健太郎、杉本誠一郎、山根正修、大藤剛宏、渡部昌実、那須保友、公文裕巳、三好新一郎、豊岡伸一
- Organizer
  第56回日本肺癌学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2015-11-26
- Data Source
  KAKENHI-PROJECT-25462195
[Presentation] Effect of Hsp90 inhibitor NVP-AUY922 with radiation on lung adenocarcinoma cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors2015
- Author(s)
  Yuho Maki, Shinsuke Hashida, Hiromasa Yamamoto, Kazuhiko Shien, Tomoaki Ohtsuka, Ken Suzawa, Masashi Furukawa, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi, Susumu Kanazawa, Shinichi Toyooka
- Organizer
  AACR 106th Annual Meeting
- Place of Presentation
  米国
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25293302
[Presentation] Anti-tumor effect of afatinib, an irreversible EGFR/HER2 dual inhibitor, in lung cancers harboring HER2 oncogene2015
- Author(s)
  Ken Suzawa, Shinichi Toyooka, Masakiyo Sakaguchi, Tomoaki Ohtsuka, Mototsugu Watanabe, Shinsuke Hashida, Yuho Maki, Hiromasa Yamamoto, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi
- Organizer
  AACR Annual Meeting 2015
- Place of Presentation
  Philadelphia, USA
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293318
[Presentation] Anti-tumor effect of a bis-anilino pyrimidine compound TAE226 on EGFR-mutant non-small cell lung cancer cells with or without T790M mutation2015
- Author(s)
  Hiromasa Yamamoto, Hiroki Otani, Munenori Takaoka, Masakiyo Sakaguchi, Junichi Soh, Masaru Jida, Tsuyoshi Ueno, Takafumi Kubo, Hiroaki Asano, Kazunori Tsukuda, Katsuyuki Kiura, Shinji Hatakeyama, Eiji Kawahara, Yoshio Naomoto, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  第74回日本癌学会総会
- Place of Presentation
  名古屋
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25293302
[Presentation] TAE226, a bis-anilino pyrimidine compound, shows anti-tumor effect on EGFR-mutant non-small cell lung cancer cells including T790M mutant2015
- Author(s)
  Hiromasa Yamamoto, Hiroki Otani, Munenori Takaoka, Masakiyo Sakaguchi, Junichi Soh, Masaru Jida, Tsuyoshi Ueno, Takafumi Kubo, Hiroaki Asano, Kazunori Tsukuda, Katsuyuki Kiura, Shinji Hatakeyama, Eiji Kawahara, Yoshio Naomoto, Shinichiro Miyoshi, Shinichi Toyooka
- Organizer
  16th World Conference on Lung Cancer
- Place of Presentation
  米国
- Year and Date
  2015-09-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25293302
[Presentation] HER2関連肺癌に対するアファチニブの抗腫瘍効果2015
- Author(s)
  諏澤　　憲，豊岡　伸一，大塚　智昭，渡邉　元嗣，橋田　真輔，牧　　佑歩，山本　寛斉，宗　　淳一，岡田　真典，伊賀　徳周，三好健太郎，杉本誠一郎，山根　正修，大藤　剛宏，三好新一郎
- Organizer
  第58回関西胸部外科学会学術集会
- Place of Presentation
  岡山
- Year and Date
  2015-06-12
- Data Source
  KAKENHI-PROJECT-26293318
[Presentation] The molecular characters of acquired resistant non-small cell lung cancer cells to afatinib2014
- Author(s)
  Shinsuke Hashida, Shinichi Toyooka, Tomoaki Ohtsuka, Ken Suzawa, Kazuhiko Shien, Hiromasa Yamamoto, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda,Shinichiro Miyoshi
- Organizer
  AACR Annual Meeting 2014
- Place of Presentation
  San Diego, California, U.S.A
- Data Source
  KAKENHI-PROJECT-25293302
[Presentation] The molecular characters of acquired resistant non－small cell lung cancer cells to afatinib
- Author(s)
  Shinsuke Hashida, Shinichi Toyooka, Tomoaki Ohtsuka, Ken Suzawa, Kazuhiko Shien, Hiromasa Yamamoto, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyosh
- Organizer
  AACR Annual Meeting 2014
- Place of Presentation
  San Diego, California, U.S.A
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-25293302
[Presentation] Anti-tumor effect of afatinib, an irreversible EGFR/HER2 dual inhibitor, in lung cancers harboring HER2 oncogene
- Author(s)
  Ken Suzawa, Shinichi Toyooka, Masakiyo Sakaguchi, Tomoaki Ohtsuka, Mototsugu Watanabe, Shinsuke Hashida, Yuho Maki, Hiromasa Yamamoto, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi
- Organizer
  AACR Annual Meeting 2015
- Place of Presentation
  Philadelphia, PA, USA
- Year and Date
  2015-04-18 – 2015-04-22
- Data Source
  KAKENHI-PROJECT-26293318
[Presentation] 新規HER2膜貫通部領域遺伝子変異の機能解析
- Author(s)
  諏澤憲、阪口政清、山本寛斉、宗淳一、牧佑歩、橋田真輔、大塚智昭、渡邉元嗣、浅野博昭、佃和憲、三好新一郎、豊岡伸一
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26293318
[Presentation] Effect of Hsp90 inhibitor NVP-AUY922 with radiation on lung adenocarcinoma cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors
- Author(s)
  Yuho Maki, Shinsuke Hashida, Hiromasa Yamamoto, Kazuhiko Shien, Tomoaki Ohtsuka, Ken Suzawa, Masashi Furukawa, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Shinichiro Miyoshi, Susumu Kanazawa, Shinichi Toyooka.
- Organizer
  AACR Annual Meeting 2015
- Place of Presentation
  Philadelphia, PA, USA
- Year and Date
  2015-04-18 – 2015-04-22
- Data Source
  KAKENHI-PROJECT-24791462

1. Toyooka Shinichi (30397880)

# of Collaborated Projects: 19 results

# of Collaborated Products: 50 results
2. SOH Junichi (90559890)

# of Collaborated Projects: 13 results

# of Collaborated Products: 45 results
3. 諏澤憲 (90839713)

# of Collaborated Projects: 12 results

# of Collaborated Products: 10 results
4. 冨田秀太 (10372111)

# of Collaborated Projects: 11 results

# of Collaborated Products: 21 results
5. 阪口政清 (70379840)

# of Collaborated Projects: 9 results

# of Collaborated Products: 14 results
6. MIYOSHI Shinichiro (00190827)

# of Collaborated Projects: 7 results

# of Collaborated Products: 21 results
7. SHIEN Kazuhiko (30708079)

# of Collaborated Projects: 6 results

# of Collaborated Products: 16 results
8. TSUKUDA Kazunori (20346430)

# of Collaborated Projects: 5 results

# of Collaborated Products: 19 results
9. ASANO Hiroaki (70534775)

# of Collaborated Projects: 4 results

# of Collaborated Products: 12 results
10. 岡崎幹生 (50467750)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
11. OHTSUKA Tomoaki

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
12. MATSUDA Fumihiko (50212220)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 片山博志 (90713975)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 枝園忠彦 (30509451)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
15. 光冨徹哉 (70209807)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 須田健一 (30631593)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 宮原信明 (70335610)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
18. 大橋圭明 (60729193)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. 山本英喜 (10581697)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 江口傑徳 (20457229)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. 加藤竜司 (50377884)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. 牧佑歩 (20549878)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
23. 山下素弘 (40284103)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. 大谷真二 (10770779)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
25. 山根正修 (20432643)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
26. 坂上倫久 (20709266)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
27. 木下理恵 (40518297)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
28. 杉本誠一郎 (40570148)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
29. 冨樫庸介 (80758326)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
30. CHEN Haiyang

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
31. NAGASAKA Takeshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
32. SATO Hiroki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
33. WATANABE Masami

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
34. 村田等

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
35. 山本健一

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results
36. 西堀正洋

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
37. 武藤学

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
38. 久保寿夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
39. 木浦勝行

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
40. 三浦克之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Yamamoto Hiromasa 山本 寛斉

YAMAMOTO Hiromasa 山本 寛斉

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploration of the novel therapeutic target for lung cancer based on the analysis of the characteristics of tumor cells derived from 3D culturePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Novel therapeutic strategy focused on EGFR-binding protein LRIG1 for EGFR-mutant lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clarification of the mechanism of drug resistance focused on microRNAs associated with epithelial-mesenchymal transition in lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Yamamoto Hiromasa 山本寛斉

YAMAMOTO Hiromasa 山本寛斉